TY - JOUR
T1 - Burden of non-communicable disease studies in Europe
T2 - a systematic review of data sources and methodological choices
AU - Charalampous, Periklis
AU - Gorasso, Vanessa
AU - The COST Action CA18218 Participants
AU - Plass, Dietrich
AU - Pires, Sara M.
AU - Von Der Lippe, Elena
AU - Mereke, Alibek
AU - Idavain, Jane
AU - Kissimova-Skarbek, Katarzyna
AU - Morgado, Joana Nazare
AU - Ngwa, Che Henry
AU - Noguer, Isabel
AU - Padron-Monedero, Alicia
AU - Santi-Cano, María Jose
AU - Sarmiento, Rodrigo
AU - Devleesschauwer, Brecht
AU - Haagsma, Juanita A.
AU - Ádám, Balázs
AU - Alkerwi, Ala'a
AU - Bikbov, Boris
AU - Bølling, Anette Kocbach
AU - Breitner, Susanne
AU - Cuschieri, Sarah
AU - Dahm, Christina C.
AU - Eikemo, Terje Andreas
AU - Fischer, Florian
AU - Freitas, Alberto
AU - García-González, Juan Manuel
AU - Gazzelloni, Federica
AU - Gissler, Mika
AU - Hengl, Brigita
AU - Hynds, Paul
AU - Isola, Gaetano
AU - Jakobsen, Lea S.
AU - Kabir, Zubair
AU - Knudsen, Ann Kristin
AU - Konar, Naime Meriç
AU - Ladeira, Carina
AU - Liew, Aaron
AU - Majer, Marjeta
AU - Mechili, Enkeleint A.
AU - Mevsim, Vildan
AU - Milicevic, Milena Santric
AU - Mitchell, Louise
AU - Monasta, Lorenzo
AU - Mondello, Stefania
AU - Nena, Evangelia
AU - Ng, Edmond S.W.
AU - Niranjan, Vikram
AU - O'Caoimh, Rónán
AU - O'Donovan, Mark Ryan
N1 - Publisher Copyright:
© 2022 The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association.
PY - 2022/4
Y1 - 2022/4
N2 - Background: Assessment of disability-adjusted life years (DALYs) resulting from non-communicable diseases (NCDs) requires specific calculation methods and input data. The aims of this study were to (i) identify existing NCD burden of disease (BoD) activities in Europe; (ii) collate information on data sources for mortality and morbidity; and (iii) provide an overview of NCD-specific methods for calculating NCD DALYs. Methods: NCD BoD studies were systematically searched in international electronic literature databases and in grey literature. We included all BoD studies that used the DALY metric to quantify the health impact of one or more NCDs in countries belonging to the European Region. Results: A total of 163 BoD studies were retained: 96 (59%) were single-country or sub-national studies and 67 (41%) considered more than one country. Of the single-country studies, 29 (30%) consisted of secondary analyses using existing Global Burden of Disease (GBD) results. Mortality data were mainly derived (49%) from vital statistics. Morbidity data were frequently (40%) drawn from routine administrative and survey datasets, including disease registries and hospital discharge databases. The majority (60%) of national BoD studies reported mortality corrections. Multimorbidity adjustments were performed in 18% of national BoD studies. Conclusion: The number of national NCD BoD assessments across Europe increased over time, driven by an increase in BoD studies that consisted of secondary data analysis of GBD study findings. Ambiguity in reporting the use of NCD-specific BoD methods underlines the need for reporting guidelines of BoD studies to enhance the transparency of NCD BoD estimates across Europe.
AB - Background: Assessment of disability-adjusted life years (DALYs) resulting from non-communicable diseases (NCDs) requires specific calculation methods and input data. The aims of this study were to (i) identify existing NCD burden of disease (BoD) activities in Europe; (ii) collate information on data sources for mortality and morbidity; and (iii) provide an overview of NCD-specific methods for calculating NCD DALYs. Methods: NCD BoD studies were systematically searched in international electronic literature databases and in grey literature. We included all BoD studies that used the DALY metric to quantify the health impact of one or more NCDs in countries belonging to the European Region. Results: A total of 163 BoD studies were retained: 96 (59%) were single-country or sub-national studies and 67 (41%) considered more than one country. Of the single-country studies, 29 (30%) consisted of secondary analyses using existing Global Burden of Disease (GBD) results. Mortality data were mainly derived (49%) from vital statistics. Morbidity data were frequently (40%) drawn from routine administrative and survey datasets, including disease registries and hospital discharge databases. The majority (60%) of national BoD studies reported mortality corrections. Multimorbidity adjustments were performed in 18% of national BoD studies. Conclusion: The number of national NCD BoD assessments across Europe increased over time, driven by an increase in BoD studies that consisted of secondary data analysis of GBD study findings. Ambiguity in reporting the use of NCD-specific BoD methods underlines the need for reporting guidelines of BoD studies to enhance the transparency of NCD BoD estimates across Europe.
UR - http://www.scopus.com/inward/record.url?scp=85128161284&partnerID=8YFLogxK
U2 - 10.1093/eurpub/ckab218
DO - 10.1093/eurpub/ckab218
M3 - Review article
C2 - 35015851
AN - SCOPUS:85128161284
SN - 1101-1262
VL - 32
SP - 289
EP - 296
JO - European Journal of Public Health
JF - European Journal of Public Health
IS - 2
ER -